Aldeyra Therapeutics, Inc. (ALDX)

3d ago, source: Yahoo Finance

LEXINGTON, Mass., October 03, 2024--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune ...

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

19d ago, source: Morningstar

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases ...

Aldeyra Therapeutics (NASDAQ:ALDX) Stock, Short Interest Report

15d ago, source: Benzinga.com

Short interest in Aldeyra Therapeutics Inc (NASDAQ:ALDX) decreased during the last reporting period, falling from 3.11M to 2.98M. This put 6.04% of the company's publicly available shares short.

Aldeyra Therapeutics extends loan agreement terms

19d ago, source: Investing

LEXINGTON, MA – Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), a pharmaceutical company, has announced the extension of its loan agreement terms through an amendment with Hercules Capital (NYSE:HTGC), Inc.

Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

27d ago, source: ADVFN

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases ...

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

18d ago, source:

The Prescription Drug User Fee Act target guidelines for NDA resubmissions include acknowledgment of acceptance for review within 30 days of submission, and completion of submission review within 6 ...

Aldeyra Therapeutics Inc ALDX

12d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

19d ago, source: Yahoo Finance

LEXINGTON, Mass., October 03, 2024--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and ...

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

18d ago, source: Yahoo Finance

LEXINGTON, Mass., October 03, 2024--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to ...